HopeStage
Back to all studies
CompletedNCT03548714

PT150 Safety With Alcohol Use

About this titleRead the official source — NCT03548714
Medication studyAges 21–64United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 21 years to 64 years.

Listed locations
HoustonSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: September 1, 2018
Recruitment status
Completed
Enrollment listed in the registry
10
Sponsor
Pop Test Oncology LLC
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 21 Years to 64 Years
Official registry ID
NCT03548714
Official title
Show the full official title

PT150 (Formerly ORG34517) as a Potential Treatment for Alcohol Dependence-Alcohol Interaction Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Houston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Pop Test Oncology LLC.

Did this study involve medication?

Yes. The study involved medication, including PT150.

Who was this study for?

Listed age limits: 21 years to 64 years.

Want to explore more studies?

Explore studies